Cystic fibrosis carrier testing in pregnancy in Canada

R. Douglas Wilson, Gregory Davies, Valerie Desilets, Gregory J. Reid, Dorothy Shaw, Anne Summers, Philip Wyatt, David Young, Joan Crane, Anthony Armson, Sandra de la Ronde, Dan Farine, Line Leduc, John Van Aerde

Résultat de recherche: Articleexamen par les pairs

18 Citations (Scopus)

Résumé

OBJECTIVE: To assess the role of cystic fibrosis (CF) testing within the Canadian health care environment. METHODS: The Genetics and Maternal Fetal Medicine Committees of the Society of Obstetricians and Gynaecologists of Canada (SOGC) reviewed Preconception and Prenatal Carrier Screening for Cystic Fibrosis Clinical and Laboratory Guidelines produced by the American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG) and other educational material from ACOG and ACMG. RESULTS: Background information related to cystic fibrosis, genetic mutation analysis, and one large clinical cystic fibrosis screening trial are reviewed. EVIDENCE: The quality of evidence reported in this document has been described using the Evaluation of Evidence criteria outlined in the report of the Canadian Task Force on the Periodic Health Exam. RECOMMENDATIONS: 1. CF testing in pregnancy is indicated for individuals who may be at increased risk for CF due to considerations of family history or clinical manifestations. (II-2A). 2. Before CF screening could be undertaken, each province/territory would have to review the ethnic diversity of its reproductive population to ensure that CF screening would be appropriate. (III-C). 3. Screening of all women during pregnancy for CF carrier status cannot be recommended at this time. (III-C).

Langue d'origineEnglish
Pages (de-à)644-647
Nombre de pages4
JournalJournal of Obstetrics and Gynaecology Canada
Volume24
Numéro de publication8
DOI
Statut de publicationPublished - 2002
Publié à l'externeOui

ASJC Scopus Subject Areas

  • Obstetrics and Gynaecology

Empreinte numérique

Plonger dans les sujets de recherche 'Cystic fibrosis carrier testing in pregnancy in Canada'. Ensemble, ils forment une empreinte numérique unique.

Citer